Shanghai Conant Optical Co., Ltd. (HKG:2276)

Market Cap	15.31B -25.3%
Revenue (ttm)	2.43B +6.1%
Net Income	620.64M +30.2%
EPS	1.34 +16.8%
Shares Out	484.09M
PE Ratio	23.68
Forward PE	19.62
Dividend	0.41 (1.28%)
Ex-Dividend Date	Jun 15, 2026

Volume	3,906,500
Open	30.88
Previous Close	31.00
Day's Range	30.20 - 32.18
52-Week Range	27.26 - 66.50
Beta	0.31
Analysts	Strong Buy
Price Target	64.66 (+104.49%)
Earnings Date	Aug 17, 2026

About Shanghai Conant Optical

Shanghai Conant Optical Co., Ltd. manufactures and sells resin spectacle lenses in Mainland China, the Americas, Asia, Europe, Oceania, and Africa. The company offers personalized, customized, and standardized lenses, such as UV++ series, 1.74 series, single vison, student, progressive, hi-vex, business, specialty, and anti-fog lenses, as well as UV shield and gaming glasses. It also provides after-sales support services. The company serves spectacle lens brand owners and international ophthalmic optic companies. Shanghai Conant Optical Co., Lt...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1996
• Employees: 2,890
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2276

Financial Performance

In 2025, Shanghai Conant Optical's revenue was 2.19 billion, an increase of 6.08% compared to the previous year's 2.06 billion. Earnings were 557.72 million, an increase of 30.22%.

Financial numbers in CNY

Analyst Summary

According to 9 analysts, the average rating for 2276 stock is "Strong Buy." The 12-month stock price target is $64.66, which is an increase of 104.49% from the latest price.

Price Target

$64.66

(104.49% upside)

Analyst Consensus: Strong Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 1, 2026

Data Sources Report a data error